标题 |
[求助补充材料] Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study
在EGFR酪氨酸激酶抑制剂治疗后进展的EGFR T790M突变非小细胞肺癌患者中使用贝弗替尼(D-0316)的有效性和安全性:一项2期、多中心、单组、开放性研究
|
网址 | |
DOI |
10.1016/j.jtho.2022.06.00
doi
|
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |